Pulmonary Hypertension Articles & Analysis
6 articles found
The preCARDIA system includes a pump console and a catheter (Figure 7D) that is introduced through the internal jugular vein and positioned into the pulmonary artery much like a standard pulmonary artery catheter. A balloon located on the shaft of the catheter is positioned in the SVC superior to the junction with the right atrium. ...
Their BASHIR™ Endovascular Catheters are a series of pharmaco-mechanical endovascular catheters which physicians are beginning to use to treat their patients suffering from thromboembolic conditions, such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) with excellent clinical outcomes. At Silicon Review, we know that this type of focus is an intentional, ...
Up to 35% to 50% of patients with PE who are treated with anticoagulation therapy alone, experience post-PE syndrome, chronic thromboembolic disease (CTED) and chronic thromboembolic pulmonary hypertension (CTEPH). In addition, up to one third of these patients are readmitted to the hospital within the first ten years post treatment. ...
“With the V-LAP, physicians have remote access to left atrial pressure — potentially informative and effective data for treating heart failure patients, especially the ones with concomitant pulmonary hypertension and/or mitral regurgitation. Remote monitoring of LAP has a great potential to keep those patients well and out of the ...
Wuensch also believes that the Monarch Platform will complement J&J's current pulmonary hypertension pharmaceutical division. The deal will help J&J compete with robotic surgery market leader Intuitive Surgical, who are awaiting FDA approval for a robotic-assisted bronchoscope device similar to Auris's Monarch Platform. ...
Among the exclusion criteria were chronic obstructive pulmonary disease, renal failure, bleeding disorders, pulmonary hypertension, antiarrhythmic drugs, and antibiotics. ...